Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Serum Antibody Fingerprinting for SARS-CoV-2 Variants in Infected and Vaccinated Subjects by Label-Free Microarray Biosensor

Thomas Carzaniga, Luca Casiraghi, Giovanni Nava, Giuliano Zanchetta, Tommaso Inzani, Marcella Chiari, Valentina Bollati, Sara Epis, Claudio Bandi, Alessia Lai, Gianguglielmo Zehender, Tommaso Bellini, View ORCID ProfileMarco Buscaglia
doi: https://doi.org/10.1101/2023.11.02.23297831
Thomas Carzaniga
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Casiraghi
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Nava
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuliano Zanchetta
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tommaso Inzani
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcella Chiari
2 National Research Council of Italy (SCITEC-CNR)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Bollati
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Epis
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Bandi
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessia Lai
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gianguglielmo Zehender
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tommaso Bellini
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Buscaglia
1 University of Milan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Buscaglia
  • For correspondence: marco.buscaglia{at}unimi.it
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Both viral infection and vaccination affect the antibody repertoire of a person. Here we demonstrate that the analysis of serum antibodies carries information not only on the virus type that caused the infection, but also on the specific virus variant. We developed a rapid multiplex assay providing a fingerprint of serum antibodies against five different SARS-CoV-2 variants, based on a microarray of virus antigens immobilized on the surface of a label-free reflectometric biosensor. We analyzed serum from plasma of convalescent subjects and vaccinated volunteers and extracted individual antibody profiles of both total immunoglobulin Ig and IgA fraction. We found that Ig level profiles were strongly correlated with the specific variant of infection or vaccination and that vaccinated subjects displayed larger quantity of total Ig and lower fraction of IgA relative to the population of convalescent unvaccinated subjects.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was funded by Ministero Universita e Ricerca through grants FISR 2020 COVID, VIAEREA project No. FISR2020IP-04633, PRIN 2017, project No. 2017Z55KCW, Erogazione liberale per le attivita di ricerca sul Coronavirus, No. LIBVT20COVID19SEPIS and Fondazione Romeo ed Enrica Invernizzi No. LIBVT21BAND. Luca Casiraghi and Tommaso Inzani were supported by young scientist fellowships from the UNIMI GSA-IDEA project.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of the ASST Fatebenefratelli Sacco, Milano, Italy, gave ethical approval for this work with protocol No. 379/2020 of March 2020, then amended in January 2023.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 03, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Serum Antibody Fingerprinting for SARS-CoV-2 Variants in Infected and Vaccinated Subjects by Label-Free Microarray Biosensor
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Serum Antibody Fingerprinting for SARS-CoV-2 Variants in Infected and Vaccinated Subjects by Label-Free Microarray Biosensor
Thomas Carzaniga, Luca Casiraghi, Giovanni Nava, Giuliano Zanchetta, Tommaso Inzani, Marcella Chiari, Valentina Bollati, Sara Epis, Claudio Bandi, Alessia Lai, Gianguglielmo Zehender, Tommaso Bellini, Marco Buscaglia
medRxiv 2023.11.02.23297831; doi: https://doi.org/10.1101/2023.11.02.23297831
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Serum Antibody Fingerprinting for SARS-CoV-2 Variants in Infected and Vaccinated Subjects by Label-Free Microarray Biosensor
Thomas Carzaniga, Luca Casiraghi, Giovanni Nava, Giuliano Zanchetta, Tommaso Inzani, Marcella Chiari, Valentina Bollati, Sara Epis, Claudio Bandi, Alessia Lai, Gianguglielmo Zehender, Tommaso Bellini, Marco Buscaglia
medRxiv 2023.11.02.23297831; doi: https://doi.org/10.1101/2023.11.02.23297831

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Allergy and Immunology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)